Mental Health Therapeutics: Is Psilocybin the Next Market Disruptor?
This research suggests that psilocybin reform is associated with a shift away from LSD and MDMA toward psilocybin, indicating that policy changes may reshape competitive dynamics and commercialization strategies in the emerging psychedelic therapeutics market.
04/14/2026 | By Ashutosh Bhave
